A U.S. Food and Drug Administration expert panel on Wednesday voted in favor of approval of Paratek Pharmaceuticals Inc’s antibiotic to treat bacterial pneumonia and skin infections.
The panel voted 17-1 in favor of the drug’s safety and effectiveness in treating acute bacterial skin and skin structure infections, and voted 14-4 for treating community acquired bacterial pneumonia.
https://in.reuters.com/article/us-paratek-pharms-fda/u-s-fda-panel-backs-approval-of-parateks-antibiotic-idINKBN1KT2C0?feedType=RSS&feedName=health